Literature DB >> 1432309

First- and third-order models for determining arterial compliance.

S M Finkelstein1, J N Cohn.   

Abstract

BACKGROUND: Engineering models of the arterial vasculature have been used to describe vascular properties of resistance and compliance. These approaches have used either Fourier frequency analysis, based on transmission line equations, or time domain analysis of the circuit equations describing modified Windkessel models of the vasculature.
DESIGN: A third-order, four-element modified Windkessel model can reproduce arterial pressure waveforms, including both exponential and oscillatory pressure decays observed during the diastolic portion of the cardiac cycle.
METHOD: A method to determine both capacitive and oscillatory compliance of the arterial vasculature was developed, and the effect of these compliance properties on the blood pressure waveform was examined.

Mesh:

Year:  1992        PMID: 1432309

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  32 in total

1.  Reproducibility of arterial elasticity parameters derived from radial artery diastolic pulse contour analysis: the multi-ethnic study of atherosclerosis.

Authors:  Lyndia C Brumback; David R Jacobs; Norma Dermond; Haiying Chen; Daniel A Duprez
Journal:  Blood Press Monit       Date:  2010-12       Impact factor: 1.444

Review 2.  Monitoring vascular health beyond blood pressure.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

3.  Large and small arterial elasticity in healthy active and sedentary premenopausal women.

Authors:  Anette S Fjeldstad; Debra Bemben
Journal:  J Sports Sci Med       Date:  2007-06-01       Impact factor: 2.988

Review 4.  Measuring endothelial function.

Authors:  Christopher J Lockhart; Gary E McVeigh; Jay N Cohn
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

5.  Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.

Authors:  Cuma Bulent Gul; Abdulmecit Yildiz; Alparslan Ersoy; Serdar Kahvecioglu; Burak Asiltas; Fatih Yildirim; Selime Ermurat; Saim Sag; Aysegul Oruc; Sumeyye Gullulu; Mustafa Gullulu
Journal:  Int Urol Nephrol       Date:  2015-06-06       Impact factor: 2.370

6.  Comparing Arterial Function Parameters for the Prediction of Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Elizabeth K Hom; Daniel A Duprez; David R Jacobs; David A Bluemke; Lyndia C Brumback; Joseph F Polak; Carmen A Peralta; Philip Greenland; Sheryl L Magzamen; João A C Lima; Alban Redheuil; David M Herrington; James H Stein; Dhananjay Vaidya; Pamela Ouyang; Joel D Kaufman
Journal:  Am J Epidemiol       Date:  2016-12-06       Impact factor: 4.897

7.  Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis.

Authors:  Daniel A Duprez; David R Jacobs; Pamela L Lutsey; David A Bluemke; Lyndia C Brumback; Joseph F Polak; Carmen A Peralta; Philip Greenland; Richard A Kronmal
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

Review 8.  Vascular health in children and adolescents: effects of obesity and diabetes.

Authors:  Kevin R Short; Piers R Blackett; Andrew W Gardner; Kenneth C Copeland
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

9.  Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness.

Authors:  Hans L A Nienhuis; Karina de Leeuw; Johan Bijzet; Jasper J van Doormaal; Arie M van Roon; Andries J Smit; Reindert Graaff; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2010-09-28       Impact factor: 5.156

10.  Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans.

Authors:  Y Al-Solaiman; A Jesri; Y Zhao; J D Morrow; B M Egan
Journal:  J Hum Hypertens       Date:  2009-04-30       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.